TB 500/BPC 157

Trusted Beehive Peptides TB 500/BPC 157 Source

Beehive Peptides offers the original TB 500/BPC 157 blend  – combining two of the most widely researched healing peptides into one powerful recovery vial. Each 2 mL vial contains 5 mg of Thymosin Beta 4 and 5 mg of Pentadecapeptide (BPC 157), totaling 10 mg of regenerative support.

What is TB 500/BPC 157?

TB 500 is a synthetic form of Thymosin Beta 4, known for its role in promoting actin production and supporting cellular regeneration throughout the body.

BPC 157 (Body Protecting Compound) is a pentadecapeptide derived from stomach proteins and renowned for its regenerative effects on muscle, ligaments, the gut, and the nervous system.

When used together in Dragon Pharma’s formulation, these peptides work synergistically to promote rapid healing, combat inflammation, and enhance physical resilience. You can also explore them separately via our listings for TB 500 and BPC 157.

Benefits of TB 500/BPC 157

This combination peptide therapy is widely used for:

• Injury Recovery: Accelerates soft tissue repair in tendons, ligaments, and muscle.
• Anti-inflammatory Action: Reduces systemic and localized inflammation for better mobility and healing.
• Improved Flexibility: Supports actin regulation for enhanced structural tissue function.

Dosage and Administration

The typical weekly dose ranges from 2 to 6 mg, split across 1–3 injections per week. TB 500/BPC 157 is administered subcutaneously, often in proximity to injury sites for localized impact, or in rotation for general systemic use.

Cycle Example

A sample 8-week cycle might include:

• Weeks 1–4: 2 mg injected twice weekly
• Weeks 5–8: 1 mg twice weekly for maintenance

Adjustments can be made based on injury severity, recovery goals, and response speed. This protocol is often stacked with other recovery peptides such as GHK-CU for added collagen support.

Post-Cycle Therapy (PCT)

No post-cycle therapy is required as neither TB 500 nor BPC 157 influences testosterone levels or endocrine function. Users can taper the dose or stop outright without rebound or suppression risk.

Possible Side Effects

This peptide blend is generally very well tolerated. Some users may experience:

• Mild injection site redness or discomfort
• Occasional nausea or headache
• Transient dizziness during initial weeks

These effects are rare and temporary. Ensure proper sterile technique and consult a healthcare provider if uncertain.

VIEW LAB RESULTS